University of Thessaly (UTH)
Διερεύνηση των μοριακών μηχανισμών δράσης του επαγόμενου από την υποξία μεταγραφικού παράγοντα ΗΙF-2α
Abstract
dc:descriptionHypoxia-Inducible Factor 2 (HIF-2) is a major component of the cellular response to oxygen deprivation. HIF-2 is a transcriptional activator composed of a hypoxia-inducible alpha subunit (HIF-α) and a stably expressed beta subunit HIF-1β (ARNT). Apart from oxygen, HIF-2α subunit is also controlled by oxygen-independent mechanisms that include its post-translational modification such as phosphorylation. Although HIF-2 function was correlated with ERK1/2 pathway activation, there were no data to support its direct phosphorylation by ERKs and the underlying molecular mechanism.In the first part of this thesis, we investigated the phosphorylation of HIF-2α by ERK1/2 under hypoxia. We demonstrate that HIF-2α is phosphorylated at serine residue 672. Obstruction of this phosphorylation decreases HIF-2 transcriptional activity by mislocalizing HIF-2α to the cytoplasm without affecting HIF-2α protein expression levels. Furthermore, we demonstrate that both HIF-2α nuclear accumulation and transcriptional activity is re-established by inhibiting nuclear protein export upon addition of the exportin CRM1 inhibitor, Leptomycin B. Immunofluorescent microscopy, reporter gene and immunoprecipitation experiments further demonstrate that HIF-2α associates with the exportin CRM1 in a phosphorylation-sensitive manner and identify two critical Leucine residues as part of an atypical CRM1-dependent nuclear export signal (NES) that neighbours Ser672. CRM1 inhibition or mutation of these Leu residues restores the nuclear accumulation and activity of HIF-2α that lacks the ERK1/2 modification site. In summary, we reveal a novel regulatory mechanism of HIF-2 that involves the ERK1/2-dependent phosphorylation of HIF- 2α, which controls HIF-2α nucleocytoplasmic shuttling and, thus, HIF-2 transcriptional activity. This regulatory crosstalk between ERK1/2 and HIF-2 described in this thesis, provides an alternative means to control HIF-2 activity in disease, which can potentially provide valuable tools and information for treating hypoxia-related diseases such as cancer.HIFs are major components of the regulatory mechanism that supports the adaptation of cancer cells to oxygen deprivation. Moreover, bibliographic data demonstrate the anti-cancer role of vitamin D. Although there are a few reports showing that the HIF-1α subunit is regulated by the bioactive metabolite of vitamin D, 1,25(OH)2 D, there are no data that correlate 1,25 (OH)2D to HIF-2α. The second aim of this thesis was the investigation of the effect of 1,25(OH)2D on both HIF-α subunits under hypoxic conditions in Huh7 cancer cells. Our results indicate that both HIF-α subunits protein levels are decreased in response to 1,25(OH)2D addition. This decrease of HIF-α protein levels is accompanied by the partial transcriptional inactivation of HIFs under hypoxia. Silencing of vitamin D3 receptor (VDR) experiments under hypoxic conditions showed that 1,25 (OH)2D affects both HIF-α protein levels and HIF transcriptional activity in a non-genomic fashion. Clarification of underlying molecular mechanisms that control the regulation of HIFs by vitamin D, could potentially contribute to the development of therapeutic interventions in cancer.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Gkotinakou, Ioanna-Maria
- Γκοτινάκου, Ιωάννα-Μαρία
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/45576